By Indication

Thyroid Eye Disease / Graves' Orbitopathy Market Analysis

Cross-industry research covering Thyroid Eye Disease / Graves' Orbitopathy across 1 market reportspanning Pharmaceuticals & Medical Devices — Ophthalmic Surgery.

1 Reports
1 Industries

Reports Covering Thyroid Eye Disease / Graves' Orbitopathy

Oculoplastic Surgery Market to Reach USD 8.4 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Medical Devices — Ophthalmic Surgery·Market: USD 4.8 Billion (2025)·CAGR: 7.2%

The fastest-growing single indication, with three Phase 3 programs active as of mid-2025 (NCT06625411, NCT06625398, NCT07155668) and a Phase 2 asset in evaluation (NCT06088979). Estimated U.S. TED prevalence of ~50,000 moderate-to-severe active cases provides the addressable population anchor for peak sales modeling (Claritas model).

18%

Market Share

17.5%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments